title: COPD: obstructed lungs.
abstract: CHRONIC OBSTRUCTIVE pulmonary diseases (COPD) affect 14 per cent of the population over 40 years of age. With an ageing population, the number of those requiring care for COPD is expected to increase, having a significant effect on health-care resources. COPD is projected to become the third leading cause of death globally by 2020. This disease has a major impact on economic and social well-being, and on quality of life. It is regarded as largely preventable but, once developed, is a progressive and complex condition characterised by frequent exacerbations and co-morbidities. Smoking is the primary cause of COPD but up to 30 per cent of those with COPD have never smoked. It is increasingly recognised COPD may have its origins prenatally and in early childhood. Treating exacerbations, improving exercise capacity, and delaying progression of disease are key management strategies. No curative or disease modifying therapies are available. Nurses are essential in providing comprehensive care to patients in both acute care and for long-term management. They also have a vital role to play in preserving healthy lung function in the early years of life to reduce the risk of COPD in older age.
authors: Georgina
authors: G
authors: Casey
mesh_terms: D000305:Adrenal Cortex Hormones; D029481:Bronchitis, Chronic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use; D018450:Disease Progression; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D006935:Hypercapnia / Q000503:physiopathology*; D000860:Hypoxia / Q000503:physiopathology*; D008168:Lung / Q000196:embryology / Q000382:microbiology; D064307:Microbiota / Q000502:physiology*; D029424:Pulmonary Disease, Chronic Obstructive / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D011656:Pulmonary Emphysema / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D011659:Pulmonary Gas Exchange / Q000502:physiology*; D012907:Smoking / Q000009:adverse effects*; D016540:Smoking Cessation
chemical_list: D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents